Ad5 PSA/MUC1/Brachyury-based immunotherapy vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ad5 PSA/MUC1/Brachyury-based immunotherapy vaccine, covering 2020-12-22 to 2020-12-22. Get the full timeline:
Most recent: Clinical Trial Update: Treatment of Castration Resistant Prostate Cancer Using Multi-Targeted Recombinant Ad5 PSA/MUC1/Brachyury Based Immunotherapy Vaccines [Phase 1]